Trade BioNTech ^BNTX

BioNTech Board Expansion Signals Focus On Oncology Execution And Valuation Gap

BNTX Upgraded by UBS -- Price Target Raised to $135

BioNTech (BNTX) Valuation Check After New Late Stage Oncology Data At 2026 ASCO Meeting

BioNTech (NASDAQ:BNTX) Upgraded at Sanford C. Bernstein - Daily Political

Bernstein starts BioNTech at Market Perform, sees high registration risk

Leonteq Securities AG Invests $2.61 Million in BioNTech SE Sponsored ADR $BNTX

Did Adding Oncology Veterans to the Supervisory Board Just Shift BioNTech's (BNTX) Investment Narrative? - Simply Wall St News

Assessing BioNTech (BNTX) Valuation After Prolonged Share Price Weakness And Loss Making Results

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial

Biontech SE Annual Shareholders Meeting Transcript

BioNTech Maps Oncology Push, $1B Buyback and Manufacturing Cuts at AGM

BioNTech comes to Jerusalem: Mayor Moshe Lion announces new mRNA vaccine center

CDC admits Moderna vaccine poses higher risk of heart inflammation

Berenberg Bank Cuts BioNTech (NASDAQ:BNTX) Price Target to $140.00

BioNTech (BNTX) Sees Price Target Adjustment Amid Oncology Pipeline Valuation

Why BioNTech (BNTX) Is Down 5.3% After Authorizing a $1 Billion ADS Buyback and Reaffirming 2026 Guidance

BioNTech: Profit takes precedence over health-and 1,860 employees lose their jobs in Germany - World Socialist Web Site

BioNTech (NASDAQ:BNTX) Stock Rating Upgraded by Wall Street Zen

BioNTech (NASDAQ:BNTX) to Buyback $1.00 billion in Shares

Other news to note for May 7, 2026 | BioWorld

BNTX Stock News: BioNTech Announces Layoffs as Covid-19 Revenue Slides

Wells Fargo & Company Cuts BioNTech (NASDAQ:BNTX) Price Target to $140.00

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Rating of "Moderate Buy" from Analysts

BioNTech Earnings: Clinical Development on Track, Busy Schedule for the Remainder of the Year | Morningstar

Health Care Up After Earnings - Health Care Roundup | Morningstar

BioNTech Q1 Earnings Call Highlights

BioNTech (NASDAQ:BNTX) Announces Earnings Results - Zolmax

BioNTech to cut up to 1,860 jobs as Covid jab sales drop

BioNTech (NASDAQ:BNTX) Posts Earnings Results, Beats Estimates By $0.26 EPS - Daily Political

BioNTech (BNTX) Is Down 7.5% After Tariff Jitters, Leadership Shifts And Cut Guidance Reset - Has The Bull Case Changed?

BioNTech Faces Tariff Risks And Leadership Shift As Oncology Plans Advance

BioNTech (NASDAQ:BNTX) Shares Gap Down - What's Next?

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week Ahead: U.S. Inflation Data and BoC Policy Rate in Focus

Moderna share price jumps as Oppenheimer upgrades stock

Pfizer shares sink on lower COVID revenue prospects

5 Stocks to Fall in Love with this Valentines Day

Stocks make further gains as oil bounce carries on

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk